Latest round: IPO. Victor Perlroth is the Chairman and CEO of Kodiak Sciences, a clinical-stage biopharmaceutical company developing therapeutics for retinal.
Victor Perlroth is the Chairman and CEO of Kodiak Sciences, a clinical-stage biopharmaceutical company developing therapeutics for retinal diseases. He leads the company's efforts towards Phase 3 readouts for late-stage assets including KSI-301, KSI-101, and KSI-501.
Full founder directory · Investor directory · Company funding database · Fundraising library